ADPT
Adaptive Biotechnologies Corp
NASDAQ: ADPT · HEALTHCARE · BIOTECHNOLOGY
$13.53
-3.63% today
Updated 2026-04-29
Market cap
$2.16B
P/E ratio
—
P/S ratio
7.80x
EPS (TTM)
$-0.39
Dividend yield
—
52W range
$8 – $21
Volume
1.9M
Adaptive Biotechnologies Corp (ADPT) Earnings
Quarterly earnings history, analyst estimates, and stock price reaction.
EPS beat streak
8 of 8
Last 8 quarters
Avg EPS surprise
+62.0%
Last 4 quarters
Revenue YoY growth
+51.0%
Most recent quarter
EPS YoY growth
+60.9%
Most recent quarter
Earnings surprise history (last 12 quarters)
Beat estimate Missed estimate
Quarterly EPS and revenue trend
Quarterly revenue EPS (diluted)
How the stock reacts to earnings
Avg 1-day reaction
-5.9%
Last 3 reports
Positive reaction rate
33%
1 of 3 quarters
Largest single-day move
-15.9%
2025-11-06
| Report date | EPS actual | Surprise | Close before | Close after | 1-day reaction |
|---|---|---|---|---|---|
| 2026-02-05 | $-0.09 | +50.0% | $17.30 | $15.77 | -8.8% |
| 2025-11-06 | $0.06 | +133.3% | $17.59 | $14.79 | -15.9% |
| 2025-08-05 | $-0.17 | +29.2% | $10.91 | $11.69 | +7.1% |
Quarterly earnings history
| Fiscal quarter ending | EPS estimate | EPS actual | Surprise | Revenue | YoY revenue |
|---|---|---|---|---|---|
| 2025-12-31 | $-0.18 | $-0.09 | +50.0% | $71.68M | +51.0% |
| 2025-09-30 | $-0.18 | $0.06 | +133.3% | $93.97M | +102.4% |
| 2025-06-30 | $-0.24 | $-0.17 | +29.2% | $58.88M | +36.3% |
| 2025-03-31 | $-0.31 | $-0.20 | +35.5% | $52.44M | +25.2% |
| 2024-12-31 | $-0.24 | $-0.23 | +4.2% | $47.46M | +3.7% |
| 2024-09-30 | $-0.27 | $-0.22 | +18.5% | $46.44M | +22.5% |
| 2024-06-30 | $-0.33 | $-0.31 | +6.1% | $43.19M | -11.7% |
| 2024-03-31 | $-0.34 | $-0.33 | +2.9% | $41.87M | — |
| 2023-12-31 | $-0.33 | $-0.30 | +9.1% | $45.78M | — |
| 2023-09-30 | $-0.34 | $-0.35 | -2.9% | $37.92M | — |
| 2023-06-30 | $-0.35 | $-0.33 | +5.7% | $48.93M | — |
Frequently asked questions
Has Adaptive Biotechnologies Corp beaten earnings estimates?
Adaptive Biotechnologies Corp has beaten Wall Street EPS estimates in 8 of its last 8 quarterly reports, with an average EPS surprise of +62.0% over the last 4 quarters.
How does ADPT stock react to earnings?
ADPT stock has moved an average of -5.9% in the trading day following earnings over its last 3 reports, with positive reactions in 33% of those quarters.
What is Adaptive Biotechnologies Corp's revenue growth rate?
Adaptive Biotechnologies Corp reported year-over-year revenue growth of +51.0% in its most recent quarter, with EPS growing +60.9% year-over-year.